ABI, Invitrogen, Fluorotechnics, Labcorp, FDA, Thermo Fisher Scientific, Bruker PerkinElmer, Vermillion, Quest Diagnostics, National Center for Toxicological Research, Genedata, Geneva Bioinformatics, Proxeon, University of Florida, Ariadne, Waters | GenomeWeb
ABI, Invitrogen Shareholders Approve Merger
Shareholders from Applied Biosystems and Invitrogen this week approved the $6.7 billion merger of the two companies.
In separate statements, the two companies each said that more than 98 percent of the votes cast supported the merger. The total number of votes cast for each company represented more than 80 percent of the total shares outstanding and entitled to vote at special meetings held this week by each company related to the merger.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.